Business | Published:

Too little, too late?

Nature volume 440, page 603 (30 March 2006) | Download Citation


Merger fever has finally reached Germany's drug firms. But can it cure the industry's woes? Alison Abbott reports.

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.


All prices are NET prices.

About this article

Publication history




    Further reading


    By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.

    Newsletter Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing